Medicare is rolling out a GLP-1 program priced at $50 a month. KTLA walks through who is eligible and who is left out.
Recap by typeshit. Full story at KTLA.
New generics and steady prices drove the jump in value despite fewer units sold, with Eli Lilly's tirzepatide featured in the breakdown.
A practical rundown of insurance coverage for Wegovy when it is prescribed for weight loss, aimed at people sorting out costs.
Novo has lowered what it charges for Wegovy in China. Details on the size of the cut are in the full report.
The new Medicare program could cut GLP-1 costs by thousands for people on it, though many beneficiaries will not meet the eligibility rules.
Men's Fitness looks at BPC-157 and stacked peptides, arguing that getting the dose right is only part of the picture. Only the headline is available so far.
A weekly Substack live answers whether tirzepatide has a weight loss ceiling and how to handle plateaus and emotional eating when appetite is low.
Loading…